[ORGANIZATION]
Apogee Therapeutics
Featured in 2 tracked stories · first seen
Situations
AbbVie earnings and stock performance
2 clusters · 2 sources · last updated
Latest: Glenmede Trust Co. NA Cuts Stakes in Incyte and Williams‑Sonoma
In early July 2026 AbbVie’s shares slipped modestly even as analysts raised price targets, indicating a cautious market reaction despite optimistic forecasts. By the end of the month the company released its second‑quart
Biopharma financing and deals 2026
22 clusters · 49 sources · last updated
Latest: AbbVie Q2 2026 earnings beat forecasts and announces Apogee Therapeutics acquisition
Throughout H1 2026, biotech financing and M&A accelerated. Early July saw French Abivax raise $800 m, United Therapeutics acquire Thymmune for $140 m, Vertex agree to buy Crinetics for $10 bn, and a series of partnership